Three TLR ligands are FDA-approved for cancer therapy: Bacillus Calmette-Guérin (BCG), a TLR2/4 ligand, the TLR4 ligand monophosphoryl lipid A (MPLA) and the TLR7 agonist imiquimod. This evidence concerns the gene TLR4 and cancer.